Other Species / Isoforms
  PLCL2 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
R6-m1
__MAECGrGGAAGGA
0 2
PLCL2 (human) __MAECGrGGAAGGA R6-m1
PLCL2 (mouse) __MAECGRGAAGGAL R6
PLCL2 (rat) gap -
T16-p
AAGGALPtsPGPALG
0 6
PLCL2 (human) AAGGALPtsPGPALG T16-p
PLCL2 (mouse) AAGGALPtsPsPALG T15-p
PLCL2 (rat) gap -
S17-p
AGGALPtsPGPALGA
Upstream
0 45
Treatment
  • antibody
PLCL2 (human) AGGALPtsPGPALGA S17-p
PLCL2 (mouse) AGGALPtsPsPALGA S16-p
PLCL2 (rat) gap -
G19
GALPtsPGPALGAKG
0 10
PLCL2 (human) GALPtsPGPALGAKG G19
PLCL2 (mouse) GALPtsPsPALGAKG S18-p
PLCL2 (rat) gap -
S51-p
HGRARYDsGGVSNGD
0 2
PLCL2 (human) HGRARYDsGGVSNGD S51-p
PLCL2 (mouse) HGRARYDSGGVSNGD S52
PLCL2 (rat) gap -
S60-p
GVSNGDCsLGVsGDE
0 1
PLCL2 (human) GVSNGDCsLGVsGDE S60-p
PLCL2 (mouse) GVSNGDCSLGVSGDE S61
PLCL2 (rat) gap -
S64-p
GDCsLGVsGDEARAS
0 1
PLCL2 (human) GDCsLGVsGDEARAS S64-p
PLCL2 (mouse) GDCSLGVSGDEARts S65
PLCL2 (rat) gap -
A70
VsGDEARASPTRGPR
0 1
PLCL2 (human) VsGDEARASPTRGPR A70
PLCL2 (mouse) VSGDEARtsPGRGPL T71-p
PLCL2 (rat) gap -
S71
sGDEARASPTRGPRG
0 1
PLCL2 (human) sGDEARASPTRGPRG S71
PLCL2 (mouse) SGDEARtsPGRGPLG S72-p
PLCL2 (rat) gap -
T84
RGVALAPTPSAVVCt
0 5
PLCL2 (human) RGVALAPTPSAVVCt T84
PLCL2 (mouse) LGVALARtPsPAAGP T85-p
PLCL2 (rat) gap -
S86
VALAPTPSAVVCtLP
0 7
PLCL2 (human) VALAPTPSAVVCtLP S86
PLCL2 (mouse) VALARtPsPAAGPVP S87-p
PLCL2 (rat) gap -
T91-p
TPSAVVCtLPRESKP
0 10
PLCL2 (human) TPSAVVCtLPRESKP T91-p
PLCL2 (mouse) tPsPAAGPVPRDSKP P92
PLCL2 (rat) gap -
S106-p
GGLPRRSsIIKDGtK
0 5
PLCL2 (human) GGLPRRSsIIKDGtK S106-p
PLCL2 (mouse) GGLPRRSsIIKDGTK S107-p
PLCL2 (rat) gap -
T112-p
SsIIKDGtKQKRERK
0 1
PLCL2 (human) SsIIKDGtKQKRERK T112-p
PLCL2 (mouse) SsIIKDGTKQKRERK T113
PLCL2 (rat) gap -
T121-p
QKRERKKtVsFssMP
0 88
PLCL2 (human) QKRERKKtVsFssMP T121-p
PLCL2 (mouse) QKRERKKTVsFSSMP T122
PLCL2 (rat) gap -
S123-p
RERKKtVsFssMPtE
0 73
PLCL2 (human) RERKKtVsFssMPtE S123-p
PLCL2 (mouse) RERKKTVsFSSMPTE S124-p
PLCL2 (rat) gap -
S125-p
RKKtVsFssMPtEkk
0 6
PLCL2 (human) RKKtVsFssMPtEkk S125-p
PLCL2 (mouse) RKKTVsFSSMPTEKK S126
PLCL2 (rat) gap -
S126-p
KKtVsFssMPtEkkI
0 1
PLCL2 (human) KKtVsFssMPtEkkI S126-p
PLCL2 (mouse) KKTVsFSSMPTEKKI S127
PLCL2 (rat) gap -
T129-p
VsFssMPtEkkISsA
0 5
PLCL2 (human) VsFssMPtEkkISsA T129-p
PLCL2 (mouse) VsFSSMPTEKKISSA T130
PLCL2 (rat) _____MPTEKKISSA T3
K131-ac
FssMPtEkkISsAsD
0 1
PLCL2 (human) FssMPtEkkISsAsD K131-ac
PLCL2 (mouse) FSSMPTEKKISSASD K132
PLCL2 (rat) ___MPTEKKISSASD K5
K132-ac
ssMPtEkkISsAsDC
0 1
PLCL2 (human) ssMPtEkkISsAsDC K132-ac
PLCL2 (mouse) SSMPTEKKISSASDC K133
PLCL2 (rat) __MPTEKKISSASDC K6
S135-p
PtEkkISsAsDCINS
0 1
PLCL2 (human) PtEkkISsAsDCINS S135-p
PLCL2 (mouse) PTEKKISSASDCINS S136
PLCL2 (rat) PTEKKISSASDCINS S9
S137-p
EkkISsAsDCINSMV
0 1
PLCL2 (human) EkkISsAsDCINSMV S137-p
PLCL2 (mouse) EKKISSASDCINSMV S138
PLCL2 (rat) EKKISSASDCINSMV S11
K150-ac
MVEGSELkKVRSNSR
0 1
PLCL2 (human) MVEGSELkKVRSNSR K150-ac
PLCL2 (mouse) MVEGSELKKVRSNSR K151
PLCL2 (rat) MVEGSELKKVRSNSR K24
S181-p
WEPSKKDsEKAKIDI
0 1
PLCL2 (human) WEPSKKDsEKAKIDI S181-p
PLCL2 (mouse) WEPSKKDSEKAKIDI S182
PLCL2 (rat) WEPSKKDSEKAKIDI S55
Y248-p
IWVTGLRyLISYGKH
0 1
PLCL2 (human) IWVTGLRyLISYGKH Y248-p
PLCL2 (mouse) IWVTGLRYLISYGKH Y249
PLCL2 (rat) IWVTGLRYLISYGKH Y122
S273-p
NMRTSWVsQMFSEID
0 1
PLCL2 (human) NMRTSWVsQMFSEID S273-p
PLCL2 (mouse) NMRTSWISQMFSEID S274
PLCL2 (rat) NMRTCWVSQMFSEID S147
K321-ac
ELHKSKDkAGTEVTK
0 1
PLCL2 (human) ELHKSKDkAGTEVTK K321-ac
PLCL2 (mouse) ELHKSKDKAGTEITK K322
PLCL2 (rat) ELHKSKDKTGTEITK K195
Y544-p
KLLGDKLyTTSPNVE
0 2
PLCL2 (human) KLLGDKLyTTSPNVE Y544-p
PLCL2 (mouse) KILGDKLYTTSPNME Y545
PLCL2 (rat) KILGDKLYTTSPNME Y418
Y554-p
SPNVEESyLPSPDVL
0 1
PLCL2 (human) SPNVEESyLPSPDVL Y554-p
PLCL2 (mouse) SPNMEESYLPSPDVL Y555
PLCL2 (rat) SPNMEESYLPSPDVL Y428
S577-p
KKLSSNCsGVEGDVt
0 1
PLCL2 (human) KKLSSNCsGVEGDVt S577-p
PLCL2 (mouse) KKLSSNCSGVEGDVt S578
PLCL2 (rat) KKLSSNCSGVEGDVt S451
T584-p
sGVEGDVtDEDEGAE
0 64
PLCL2 (human) sGVEGDVtDEDEGAE T584-p
PLCL2 (mouse) SGVEGDVtDEDEGAE T585-p
PLCL2 (rat) SGVEGDVtDEDEGAE T458-p
S747
FSANTKDSVPGVSPQ
0 1
PLCL2 (human) FSANTKDSVPGVSPQ S747
PLCL2 (mouse) FSANTKDsVPGVSPQ S748-p
PLCL2 (rat) FSANTKDSVPGVSPQ S621
K891
RGGGKPHKRGLSVRK
0 1
PLCL2 (human) RGGGKPHKRGLSVRK K891
PLCL2 (mouse) RGGGKPHkRGLSVRK K892-ac
PLCL2 (rat) RGGGKPHKRGLsVRK K765
S895
KPHKRGLSVRKGKKS
0 1
PLCL2 (human) KPHKRGLSVRKGKKS S895
PLCL2 (mouse) KPHkRGLSVRKGKKS S896
PLCL2 (rat) KPHKRGLsVRKGKKS S769-p
T910-p
REYASLRtLWIKtVD
0 2
PLCL2 (human) REYASLRtLWIKtVD T910-p
PLCL2 (mouse) REYASLRTLWIKTVD T911
PLCL2 (rat) REYASLRTLWIKTVD T784
T915-p
LRtLWIKtVDEVFKN
0 2
PLCL2 (human) LRtLWIKtVDEVFKN T915-p
PLCL2 (mouse) LRTLWIKTVDEVFKN T916
PLCL2 (rat) LRTLWIKTVDEVFKN T789
S951-p
FKELCGLsSVANLMQ
0 1
PLCL2 (human) FKELCGLsSVANLMQ S951-p
PLCL2 (mouse) FKELCGLSSVANLMQ S952
PLCL2 (rat) FKELCGLSSVANLMQ S825
T1002-p
EVLKKIVttyDMMIQ
0 1
PLCL2 (human) EVLKKIVttyDMMIQ T1002-p
PLCL2 (mouse) EVLKKIVTTYDMMMQ T1003
PLCL2 (rat) EVLKKIVTTYDMMIQ T876
T1003-p
VLKKIVttyDMMIQS
0 1
PLCL2 (human) VLKKIVttyDMMIQS T1003-p
PLCL2 (mouse) VLKKIVTTYDMMMQS T1004
PLCL2 (rat) VLKKIVTTYDMMIQS T877
Y1004-p
LKKIVttyDMMIQSL
0 1
PLCL2 (human) LKKIVttyDMMIQSL Y1004-p
PLCL2 (mouse) LKKIVTTYDMMMQSL Y1005
PLCL2 (rat) LKKIVTTYDMMIQSL Y878
Y1022-p
IENADAVyEkIVHCQ
0 10
PLCL2 (human) IENADAVyEkIVHCQ Y1022-p
PLCL2 (mouse) IENADAVyEKIVHCQ Y1023-p
PLCL2 (rat) IENADAVyEKIVHCQ Y896-p
K1024-ub
NADAVyEkIVHCQKA
0 1
PLCL2 (human) NADAVyEkIVHCQKA K1024-ub
PLCL2 (mouse) NADAVyEKIVHCQKA K1025
PLCL2 (rat) NADAVyEKIVHCQKA K898
K1078-ub
ADLLKYAkNETLENL
0 1
PLCL2 (human) ADLLKYAkNETLENL K1078-ub
PLCL2 (mouse) ADLLKYAKNETLENL K1079
PLCL2 (rat) ADLLKYAKNETLENL K952
S1113-p
DVQKPRRsLEVIPEK
Upstream
0 28
Treatment
  • antibody
  • ischemia
  • nocodazole
view more >
PLCL2 (human) DVQKPRRsLEVIPEK S1113-p
PLCL2 (mouse) EAQKPRRsLEAIPEK S1114-p
PLCL2 (rat) EAQKPRRsLEVIPEK S987-p